BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38281303)

  • 1. GammaTile
    Yekula A; Gessler DJ; Ferreira C; Shah R; Reynolds M; Dusenbery K; Chen CC
    J Neurooncol; 2024 Feb; 166(3):441-450. PubMed ID: 38281303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GammaTile® (GT) as a brachytherapy platform for rapidly growing brain metastasis.
    Dharnipragada R; Ferreira C; Shah R; Reynolds M; Dusenbery K; Chen CC
    Neurooncol Adv; 2023; 5(1):vdad062. PubMed ID: 37324216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GammaTile® brachytherapy in the treatment of recurrent glioblastomas.
    Gessler DJ; Neil EC; Shah R; Levine J; Shanks J; Wilke C; Reynolds M; Zhang S; Özütemiz C; Gencturk M; Folkertsma M; Bell WR; Chen L; Ferreira C; Dusenbery K; Chen CC
    Neurooncol Adv; 2022; 4(1):vdab185. PubMed ID: 35088050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GammaTile
    Gessler DJ; Ferreira C; Dusenbery K; Chen CC
    Future Oncol; 2020 Oct; 16(30):2445-2455. PubMed ID: 32618209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Interval Recurrence of Glioblastoma Following Gross Total Resection: A Possible Indication for GammaTileⓇ Brachytherapy.
    Easwaran TP; Sterling D; Ferreira C; Sloan L; Wilke C; Neil E; Shah R; Chen CC; Dusenbery KE
    Cureus; 2021 Nov; 13(11):e19496. PubMed ID: 34912636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control.
    Wernicke AG; Taube S; Smith AW; Herskovic A; Parashar B; Schwartz TH
    Brachytherapy; 2020; 19(5):705-712. PubMed ID: 32928486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GammaTile Brachytherapy Combined With External Beam Radiation Therapy for the Treatment of a Partially Resected Secondary Glioblastoma (WHO Grade 4 IDH-Mutant Astrocytoma): Matching External Beam Dose Gradient to Brachytherapy Dose Fall-Off.
    Peach MS; Burke AM; Jo J; Ju AW; Yang K
    Cureus; 2021 Nov; 13(11):e19717. PubMed ID: 34934580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GammaTile for Gliomas: A Single-Center Case Series.
    Budnick HC; Richardson AM; Shiue K; Watson G; Ng SK; Le Y; Shah MV
    Cureus; 2021 Nov; 13(11):e19390. PubMed ID: 34925992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases.
    Imber BS; Young RJ; Beal K; Reiner AS; Giantini-Larsen AM; Krebs S; Yang JT; Aramburu-Nunez D; Cohen GN; Brennan C; Tabar V; Moss NS
    J Neurooncol; 2022 Sep; 159(3):609-618. PubMed ID: 35896906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas.
    Brachman DG; Youssef E; Dardis CJ; Sanai N; Zabramski JM; Smith KA; Little AS; Shetter AG; Thomas T; McBride HL; Sorensen S; Spetzler RF; Nakaji P
    J Neurosurg; 2018 Dec; 131(6):1819-1828. PubMed ID: 30579269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Outcomes of Novel Collagen Tile Cesium Brachytherapy for Recurrent Intracranial Tumors at a Tertiary Referral Center.
    Warren KT; Boucher A; Bray DP; Dresser S; Zhong J; Shu HK; Olson J; Hoang K
    Cureus; 2021 Nov; 13(11):e19777. PubMed ID: 34950555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of GammaTile in the treatment of brain tumors: a technical and clinical overview.
    Garcia MA; Turner A; Brachman DG
    J Neurooncol; 2024 Jan; 166(2):203-212. PubMed ID: 38261141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resection and Surgically Targeted Radiation Therapy for the Treatment of Larger Recurrent or Newly Diagnosed Brain Metastasis: Results From a Prospective Trial.
    Nakaji P; Smith K; Youssef E; Thomas T; Pinnaduwage D; Rogers L; Wallstrom G; Brachman D
    Cureus; 2020 Nov; 12(11):e11570. PubMed ID: 33224684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgically targeted radiation therapy (STaRT) trials for brain neoplasms: A comprehensive review.
    Odia Y; Gutierrez AN; Kotecha R
    Neuro Oncol; 2022 Nov; 24(Suppl 6):S16-S24. PubMed ID: 36322100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of GammaTile intracranial brachytherapy implanted during awake craniotomy.
    McClelland S; Gardner UG; Le Y; Ng SK; Shah MV; Watson GA
    Brachytherapy; 2021; 20(6):1265-1268. PubMed ID: 34588144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating Recurrent Brain Metastases Using GammaTile Brachytherapy: A Case Report and Dosimetric Modeling Method.
    Arsenault T; Labak CM; Chaung K; Muzic RF; Kardan A; Sloan A; Choi S; Podder T; Ouyang Z
    Cureus; 2021 Nov; 13(11):e19232. PubMed ID: 34877209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surviving Over a Decade With Glioblastoma: A Clinical Course Characterized by Multiple Recurrences, Numerous Salvage Treatments, and Novel Use of Cesium-131 Tiles.
    Mehta S; Vassantachart AK; Fossum CC; Yang W; Shen ZL; Chang KE; Ye JC; Chen TC; Chang EL
    Cureus; 2021 Nov; 13(11):e19573. PubMed ID: 34926045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.
    Oppenlander ME; Wolf AB; Snyder LA; Bina R; Wilson JR; Coons SW; Ashby LS; Brachman D; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
    J Neurosurg; 2014 Apr; 120(4):846-53. PubMed ID: 24484232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience.
    Chatzikonstantinou G; Zamboglou N; Archavlis E; Strouthos I; Zoga E; Milickovic N; Hilaris B; Baltas D; Rödel C; Tselis N
    Strahlenther Onkol; 2018 Dec; 194(12):1171-1179. PubMed ID: 30203110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.